Market Exclusive

Analyst Activity – JPMorgan Chase & Co. Raises Its Price Target On Neurocrine Biosciences (NASDAQ:NBIX) to $100.00

Analyst Ratings For Neurocrine Biosciences (NASDAQ:NBIX)

Today, JPMorgan Chase & Co. raised its price target on Neurocrine Biosciences (NASDAQ:NBIX) to $100.00 per share.

Some recent analyst ratings include


Recent Trading Activity for Neurocrine Biosciences (NASDAQ:NBIX)
Shares of Neurocrine Biosciences closed the previous trading session at 85.26 up +1.56 1.87% with shares trading hands.

Exit mobile version